NO20023978L - 8,8A-dihydro-indeno(1,2-D)tiazolderivater, substituert i posisjon 8A, en fremgangsmåte for deres fremstilling og deresanvendelse som legemidler, for eksempel anoreksimidler - Google Patents

8,8A-dihydro-indeno(1,2-D)tiazolderivater, substituert i posisjon 8A, en fremgangsmåte for deres fremstilling og deresanvendelse som legemidler, for eksempel anoreksimidler

Info

Publication number: NO20023978L
Authority: NO; Norway
Prior art keywords: preparation; dihydroindo; drugs; substituted; thiazole derivatives
Prior art date: 2000-02-23

Application number

NO20023978A

Other languages

English (en)

Other versions

NO20023978D0 (no

Inventor

Gerhard Jaehne

Matthias Gossel

Martin Bickel

Original Assignee

Aventis Pharma Gmbh

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-02-23

Filing date

2002-08-21

Publication date

2002-10-18

2002-08-21 Application filed by Aventis Pharma Gmbh filed Critical Aventis Pharma Gmbh

2002-08-21 Publication of NO20023978D0 publication Critical patent/NO20023978D0/no

2002-10-18 Publication of NO20023978L publication Critical patent/NO20023978L/no

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/60—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

Health & Medical Sciences (AREA)
Organic Chemistry (AREA)
Chemical & Material Sciences (AREA)
Diabetes (AREA)
Life Sciences & Earth Sciences (AREA)
Public Health (AREA)
Obesity (AREA)
Bioinformatics & Cheminformatics (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Engineering & Computer Science (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Hematology (AREA)
Child & Adolescent Psychology (AREA)
Emergency Medicine (AREA)
Endocrinology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Thiazole And Isothizaole Compounds (AREA)
Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Fuses (AREA)
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Indole Compounds (AREA)

NO20023978A 2000-02-23 2002-08-21 8,8A-dihydro-indeno(1,2-D)tiazolderivater, substituert i posisjon 8A, en fremgangsmåte for deres fremstilling og deresanvendelse som legemidler, for eksempel anoreksimidler NO20023978L (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
DE10008275		2000-02-23
PCT/EP2001/001499 WO2001062746A1 (de)	2000-02-23	2001-02-12	8,8a-DIHYDRO-INDENO[1,2-d]THIAZOL-DERIVATE, DIE IN 8a-STELLUNG SUBSTITUIERT SIND; VERFAHREN ZU IHRER HERSTELLUNG UND IHRE VERWENDUNG ALS ARZNEIMITTEL Z.B. ALS ANOREKTIKA

Publications (2)

Publication Number	Publication Date
NO20023978D0 NO20023978D0 (no)	2002-08-21
NO20023978L true NO20023978L (no)	2002-10-18

Family

ID=7631989

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20023978A NO20023978L (no)	2000-02-23	2002-08-21	8,8A-dihydro-indeno(1,2-D)tiazolderivater, substituert i posisjon 8A, en fremgangsmåte for deres fremstilling og deresanvendelse som legemidler, for eksempel anoreksimidler

Country Status (26)

Country	Link
US (1)	US6403624B1 (no)
EP (1)	EP1259498B1 (no)
JP (1)	JP4898052B2 (no)
KR (1)	KR20020079891A (no)
CN (1)	CN1195747C (no)
AT (1)	ATE283265T1 (no)
AU (1)	AU781003B2 (no)
BR (1)	BR0108605A (no)
CA (1)	CA2400698A1 (no)
CZ (1)	CZ20022838A3 (no)
DE (1)	DE50104600D1 (no)
EE (1)	EE200200466A (no)
ES (1)	ES2231482T3 (no)
HR (1)	HRP20020688A2 (no)
HU (1)	HUP0300140A3 (no)
IL (1)	IL151327A0 (no)
MX (1)	MXPA02007021A (no)
NO (1)	NO20023978L (no)
NZ (1)	NZ520926A (no)
PL (1)	PL357547A1 (no)
PT (1)	PT1259498E (no)
RU (1)	RU2261860C2 (no)
SK (1)	SK12162002A3 (no)
WO (1)	WO2001062746A1 (no)
YU (1)	YU56302A (no)
ZA (1)	ZA200206487B (no)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE10142660A1 (de) *	2001-08-31	2003-03-20	Aventis Pharma Gmbh	Verwendung von Derivaten von C2-substituierten Indan-1-ol-Systemen zur Herstellung von Medikamenten zur Prophylaxe oder Behandlung von Obesitas
DE10142659A1 (de)	2001-08-31	2003-03-20	Aventis Pharma Gmbh	Verwendung von mehrfach substituierten Indan-1-ol. Systemen zur Herstellung von Medikamenten zur Prophylaxe oder Behandlung von Obesitas
US7772188B2 (en)	2003-01-28	2010-08-10	Ironwood Pharmaceuticals, Inc.	Methods and compositions for the treatment of gastrointestinal disorders
WO2005097127A2 (en)	2004-04-02	2005-10-20	Merck & Co., Inc.	Method of treating men with metabolic and anthropometric disorders
US8969514B2 (en)	2007-06-04	2015-03-03	Synergy Pharmaceuticals, Inc.	Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases
CN103601792B (zh)	2007-06-04	2016-06-29	协同医药品公司	有效用于胃肠功能紊乱、炎症、癌症和其他疾病治疗的鸟苷酸环化酶激动剂
AU2009256157B2 (en)	2008-06-04	2014-12-18	Bausch Health Ireland Limited	Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
ES2624828T3 (es)	2008-07-16	2017-07-17	Synergy Pharmaceuticals Inc.	Agonistas de la guanilato ciclasa útiles para el tratamiento de trastornos gastrointestinales, inflamación, cáncer y otros
MX2011004258A (es)	2008-10-22	2011-06-01	Merck Sharp & Dohme	Derivados de bencimidazol ciclicos novedosos utiles como agentes anti-diabeticos.
CA2741672A1 (en)	2008-10-31	2010-05-06	Merck Sharp & Dohme Corp.	Novel cyclic benzimidazole derivatives useful anti-diabetic agents
CA2786314A1 (en)	2010-02-25	2011-09-01	Merck Sharp & Dohme Corp.	Novel cyclic benzimidazole derivatives useful anti-diabetic agents
US9616097B2 (en)	2010-09-15	2017-04-11	Synergy Pharmaceuticals, Inc.	Formulations of guanylate cyclase C agonists and methods of use
SG192941A1 (en)	2011-02-25	2013-09-30	Merck Sharp & Dohme	Novel cyclic azabenzimidazole derivatives useful as anti-diabetic agents
MX357121B (es)	2011-03-01	2018-06-27	Synergy Pharmaceuticals Inc Star	Proceso de preparacion de agonistas c de guanilato ciclasa.
KR20150036245A (ko)	2012-08-02	2015-04-07	머크 샤프 앤드 돔 코포레이션	항당뇨병 트리시클릭 화합물
MX2015010935A (es)	2013-02-22	2015-10-29	Merck Sharp & Dohme	Compuestos biciclicos antidiabeticos.
EP2970119B1 (en)	2013-03-14	2021-11-03	Merck Sharp & Dohme Corp.	Novel indole derivatives useful as anti-diabetic agents
WO2014151206A1 (en)	2013-03-15	2014-09-25	Synergy Pharmaceuticals Inc.	Agonists of guanylate cyclase and their uses
US9486494B2 (en)	2013-03-15	2016-11-08	Synergy Pharmaceuticals, Inc.	Compositions useful for the treatment of gastrointestinal disorders
EP4424697A3 (en)	2013-06-05	2024-12-25	Bausch Health Ireland Limited	Ultra-pure agonists of guanylate cyclase c, method of making and using same
WO2015051496A1 (en)	2013-10-08	2015-04-16	Merck Sharp & Dohme Corp.	Antidiabetic tricyclic compounds
EP3551176A4 (en)	2016-12-06	2020-06-24	Merck Sharp & Dohme Corp.	Antidiabetic heterocyclic compounds
EP3558298A4 (en)	2016-12-20	2020-08-05	Merck Sharp & Dohme Corp.	ANTIDIABETIC SPIROCHROMAN COMPOUNDS

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3507868A (en) *	1968-10-21	1970-04-21	Sandoz Ag	Imidazo(2,1-b)thiazoles and thiazolo(3,2-a)pyrimidines
DE2640358A1 (de) *	1976-09-08	1978-03-16	Hoechst Ag	Thiazolidinderivate und verfahren zu ihrer herstellung
CA1292226C (en) *	1986-01-16	1991-11-19	Terumi Hachiya	Indenothiazole derivative and process for preparing the same
GB9517381D0 (en) *	1995-08-24	1995-10-25	Pharmacia Spa	Aryl and heteroaryl piperazine derivatives
DE19844547C2 (de) *	1998-09-29	2002-11-07	Aventis Pharma Gmbh	Polycyclische Dihydrothiazole, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
DE19908539A1 (de) *	1999-02-26	2000-08-31	Aventis Pharma Gmbh	Polycyclische 2-Amino-Dihydrothiazolsysteme, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel

2001
- 2001-02-12 BR BR0108605-7A patent/BR0108605A/pt not_active IP Right Cessation
- 2001-02-12 YU YU56302A patent/YU56302A/sh unknown
- 2001-02-12 HR HRP20020688 patent/HRP20020688A2/hr not_active Application Discontinuation
- 2001-02-12 IL IL15132701A patent/IL151327A0/xx unknown
- 2001-02-12 ES ES01929342T patent/ES2231482T3/es not_active Expired - Lifetime
- 2001-02-12 EP EP01929342A patent/EP1259498B1/de not_active Expired - Lifetime
- 2001-02-12 RU RU2002125460/04A patent/RU2261860C2/ru not_active IP Right Cessation
- 2001-02-12 JP JP2001562528A patent/JP4898052B2/ja not_active Expired - Fee Related
- 2001-02-12 SK SK1216-2002A patent/SK12162002A3/sk unknown
- 2001-02-12 NZ NZ520926A patent/NZ520926A/en unknown
- 2001-02-12 AT AT01929342T patent/ATE283265T1/de not_active IP Right Cessation
- 2001-02-12 CA CA002400698A patent/CA2400698A1/en not_active Abandoned
- 2001-02-12 HU HU0300140A patent/HUP0300140A3/hu unknown
- 2001-02-12 DE DE50104600T patent/DE50104600D1/de not_active Expired - Lifetime
- 2001-02-12 MX MXPA02007021A patent/MXPA02007021A/es active IP Right Grant
- 2001-02-12 PT PT01929342T patent/PT1259498E/pt unknown
- 2001-02-12 PL PL01357547A patent/PL357547A1/xx not_active Application Discontinuation
- 2001-02-12 EE EEP200200466A patent/EE200200466A/xx unknown
- 2001-02-12 AU AU56153/01A patent/AU781003B2/en not_active Ceased
- 2001-02-12 KR KR1020027011001A patent/KR20020079891A/ko not_active Withdrawn
- 2001-02-12 WO PCT/EP2001/001499 patent/WO2001062746A1/de not_active Ceased
- 2001-02-12 CN CNB018054919A patent/CN1195747C/zh not_active Expired - Fee Related
- 2001-02-12 CZ CZ20022838A patent/CZ20022838A3/cs unknown
- 2001-02-23 US US09/790,911 patent/US6403624B1/en not_active Expired - Lifetime
2002
- 2002-08-14 ZA ZA200206487A patent/ZA200206487B/en unknown
- 2002-08-21 NO NO20023978A patent/NO20023978L/no not_active Application Discontinuation

Also Published As

Publication number	Publication date
DE50104600D1 (de)	2004-12-30
NO20023978D0 (no)	2002-08-21
EP1259498B1 (de)	2004-11-24
WO2001062746A1 (de)	2001-08-30
US6403624B1 (en)	2002-06-11
IL151327A0 (en)	2003-04-10
SK12162002A3 (sk)	2003-02-04
JP4898052B2 (ja)	2012-03-14
AU781003B2 (en)	2005-04-28
CZ20022838A3 (cs)	2002-11-13
CN1195747C (zh)	2005-04-06
CN1423640A (zh)	2003-06-11
PT1259498E (pt)	2005-02-28
RU2261860C2 (ru)	2005-10-10
ATE283265T1 (de)	2004-12-15
YU56302A (sh)	2005-11-28
US20020058658A1 (en)	2002-05-16
ZA200206487B (en)	2003-10-16
PL357547A1 (en)	2004-07-26
ES2231482T3 (es)	2005-05-16
BR0108605A (pt)	2002-11-19
AU5615301A (en)	2001-09-03
NZ520926A (en)	2004-08-27
HRP20020688A2 (en)	2004-12-31
JP2003528825A (ja)	2003-09-30
HK1055117A1 (en)	2003-12-24
HUP0300140A2 (en)	2003-05-28
MXPA02007021A (es)	2003-03-27
EP1259498A1 (de)	2002-11-27
KR20020079891A (ko)	2002-10-19
RU2002125460A (ru)	2004-01-10
HUP0300140A3 (en)	2004-10-28
EE200200466A (et)	2003-12-15
CA2400698A1 (en)	2001-08-30

Publication	Publication Date	Title
NO20023978L (no)	2002-10-18	8,8A-dihydro-indeno(1,2-D)tiazolderivater, substituert i posisjon 8A, en fremgangsmåte for deres fremstilling og deresanvendelse som legemidler, for eksempel anoreksimidler
NO20023977D0 (no)	2002-08-21	8,8A-dihydro-indeno(1,2-D)tiazolderivater med en sulfonamid- eller sulfon substituert i 2-posisjonen, en fremgangsmåte forfremstilling derav og anvendelse som et legemiddel
BR0016543A (pt)	2002-09-17	Novos derivados de piperidina e piperazina
JO2353B1 (en)	2006-12-12	New derivatives of mixed-ring fluoroglycosides and drugs containing these compounds and their use
AP1753A (en)	2007-07-18	Thiophene derivatives as antiviral agents for flavvivirus infection
ES2243579T3 (es)	2005-12-01	Derivados de pirazolopirideno.
BRPI0409376A (pt)	2006-04-25	derivados de indeno como agentes farmacêuticos
PT992509E (pt)	2004-12-31	Novos derivados macrolidos
NO20062491L (no)	2006-09-06	Benzoksazinderivter og deres anvendelse
CY1105939T1 (el)	2011-04-06	Παραγωγα βενζοθειαζινης και βενζοθεαδιαζινης, μεθοδος παρασκευης αυτων και φαρμακευτικες συνθεσεις οι οποιες τα πepιεχουν
SE0102057D0 (sv)	2001-06-08	New Salts I
GEP20063759B (en)	2006-02-27	Novel Benzothiazine and Benzothiadiazine Derivatives, Method for Preparing Same and Pharmaceutical Compositions Containing Same
PT1183247E (pt)	2005-07-29	Sistemas tiazole policiclicos e sua utilizacao como anorecticos
HUP0401895A2 (hu)	2004-12-28	Paroxetin N-formil származékai, eljárás az előállításukra és ezeket tartalmazó gyógyszerkészítmények
NO20023955L (no)	2002-09-19	Substituerte 8,8a-dihydro-3aH-indeno[1,2-d]tiazoler, en fremgangsmåte for fremstilling og deres anvendelse sommedikamenter
BR9915898A (pt)	2001-08-21	Compostos, composição farmacêutica, e, utilização de um composto
NO20025031D0 (no)	2002-10-18	Benzoksazin- og benzotiazinderivater og anvendelsen derav i medikamenter
DE50008905D1 (de)	2005-01-13	Polycyclische thiazol-2-yliden amine, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel

Legal Events

Date	Code	Title	Description
2006-10-02	FC2A	Withdrawal, rejection or dismissal of laid open patent application